Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
If you click a phishing link, act quickly: disconnect, scan devices, change passwords, and report the incident to protect your crypto assets.
17,697 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Investing in rare earths sits at the intersection of policy, manufacturing demand, and new mining projects. This guid...
Insider activity often sparks debate among investors. This article breaks down AXT's sold shares worth $1.41 million ...
Kennametal’s Q3 2026 results shed light on the company’s path through a challenging manufacturing environment. This a...
NVIDIA led the AI chip boom, but growing competition and supply forces may erode its edge. This guide breaks down the...
A recent SEC filing shows Marshall Investment Management adding a sizable stake to the TCW Flexible Income ETF (FLXR)...
Qualcomm sits at the intersection of 5G, auto tech, and AI. This article explores the key catalysts that could send t...
A 56-year-old couple with $2.7 million saved must rethink withdrawal plans for a 35- to 40-year retirement, adopting ...
NVDY is pursuing income by selling Nvidia’s strongest move days, financing a roughly 60% distribution. The strategy b...
A spotlight on KNG shows it earns an 8.6% yield by selling covered calls on Dividend Aristocrats, but eight-year retu...
A retiree trades a large bequest for a guaranteed monthly check for life. The decision hinges on inflation, longevity...
For investors seeking reliable, long-term growth in energy, midstream pipelines stand out. Here are three brilliant e...